On September 10, 2019, Baidu and People's Medical Publishing House (referred to as "Huaweishe") formally signed a strategic cooperation agreement. Both parties will be based on Baidu's leading and comprehensive artificial intelligence technology, Renhehe's top medical content and expert resources. Work together to build China's most authoritative evidence-based medicine knowledge system, and work together to promote the continuous implementation of CDSS (Clinical Assistant Decision System) suitable for China's national conditions. In addition, the two sides will carry out multi-dimensional and all-round cooperation in the production, dissemination and application of medical knowledge, and work together to improve China's primary medical services and promote healthy life for all.
Photo: Wang Xuening, general manager and deputy secretary of the party committee and director of People's Medical Publishing House, and Huang Yan, general manager of Baidu Smart Medical, signed a strategic cooperation agreement on behalf of the two parties
As an important part of protecting people's livelihood, how to provide primary medical services professionally and efficiently has always attracted attention from all walks of life. Among them, the improvement of primary doctors' ability is particularly critical. Only when the quality of primary medical care has been widely and authoritatively recognized can patients have more trust. Only at the grassroots level can a closed loop of graded diagnosis and treatment be finally formed. The key to improving the ability of doctors is to present standardized and standardized decision support information to doctors in the most effective way and at the most appropriate time in the clinical environment. On the one hand, it needs to build a core content knowledge base based on authoritative medical knowledge. On the other hand, on the other hand, artificial intelligence technology needs to be combined with clinical practice, so as to effectively promote knowledge and clinical judgment.
After Baidu proposed its artificial intelligence development strategy, it also paid special attention to AI empowerment in the medical industry. In 2018, Baidu set up a smart medical department to use artificial intelligence technology as the primary medical empowerment, and recently upgraded the AI medical brand to "Lingyi Zhihui". With the vision of "Evidence-Based AI Empowering Primary Care", Linghui Zhihui is committed to serving all scenarios in and out of the hospital and helping to improve the ability of primary care services. Among them, the CDSS (Clinical Assistant Decision System) aimed at improving the capabilities of doctors has landed in more than 1,000 medical institutions across the country and received wide acclaim.
The two sides signed a strategic cooperation this time, relying on the massive and authoritative medical knowledge content resources such as books, academic monographs, diagnosis and treatment guidelines, expert consensus, and clinical cases of People ’s Medical Publishing House, using Baidu natural language processing, semantic understanding, knowledge graphs, machine learning, Leading artificial intelligence technology advantages such as deep learning will structure, label and cluster medical content resources to jointly build the most authoritative evidence-based medical knowledge system in the medical industry, so that more basic medical staff can have more comprehensive and accurate medicine Information for reference and learning.
In addition, the two parties will use their respective advantages to develop a CDSS (Clinical Decision Assist System) that conforms to China's national conditions through the integration of Baidu brain AI technology and medical knowledge to provide effective support for primary-level medical personnel.
On the one hand, People's Medical Publishing House is the world's only health information and publishing cooperation center in the world, with high-quality and rich content resources, expert resources and user resources. On the other hand, Baidu, as the head of artificial intelligence in China, has comprehensive and advanced open technologies such as speech, images, natural language processing, knowledge graphs, development services, and comprehensive solutions in the field of AI.
At the signing site, Hao Yang, chairman and party secretary of People's Medical Publishing House, said that Baidu is the world's largest Chinese search engine and the world's leading artificial intelligence company. The strategic cooperation between the two parties to build the most authoritative evidence-based medical knowledge system in the medical industry is of great significance for the implementation of the "Healthy China 2030" strategic plan and the era of "healthy application of comprehensive intelligent connectivity". "It will also help to improve the efficiency and quality of primary medical care and share the burden of the top three hospitals."
Huang Yan, general manager of Baidu Smart Healthcare and "Lingyi Zhihui" also once again publicly stated that the process of integration of the medical industry and AI technology will be bumpy. Making cars behind closed doors is definitely not the spirit of the AI era. Jointly promote the application of AI in the field of medical health. With a large publishing scale, high product quality, and strong comprehensive strength, Renheishe is a leading domestic and internationally influential medical and health publishing and media enterprise. This time, the two sides will combine medical professional capabilities and artificial intelligence technology to carry out close cooperation in the construction of medical knowledge and the establishment of grass-roots clinical assistant decision-making systems, etc., which will jointly provide support for the empowerment of Chinese medical treatment, especially primary medical treatment.
There is a broad consensus between the People's Medical Publishing House and "Spiritual Medicine Zhihui" in the field of AI medical treatment. Based on artificial intelligence technology, the two parties will work together in multiple dimensions, through brands, project projects, markets, channels, etc., to create a shared brand, share intellectual property rights, cooperate with national projects, promote the spread of authoritative professional knowledge, and actively In the direction of AI medical treatment, we will continue to expand cooperation areas, spare no effort to promote the deepening and upgrading of cooperation, and bring useful exploration results for AI + medical treatment.
